Effect of 3 licensed asthma drugs on allergen challenge
Research type
Research Study
Full title
A Two-Part, Randomized, Placebo-Controlled, Crossover Trial to Evaluate the Differential Effects of Inhaled Nedocromil, Oral Montelukast, and Inhaled Mometasone on Markers of the Early Airway Response to Allergen in Asthmatics
IRAS ID
43270
Contact name
Leonard Siew
Contact email
Sponsor organisation
Merck Sharp & Dohme Corp.
Eudract number
2009-017863-40
ISRCTN Number
xx
Research summary
The import did not bring in any data, please check the applicants form to see if they filled in the Research Summary. If so please import the form again. This problem may have been caused by the an application form being imported before the research summary functionality was available. Please phone the helpdesk if you have any questions or require advice.
REC name
London - Westminster Research Ethics Committee
REC reference
10/H0802/8
Date of REC Opinion
17 Feb 2010
REC opinion
Further Information Favourable Opinion